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Fig. 2. Kaplan–Meier survival curve showing the different severity
progression between carriers of the haplogroup H and non-H carriers.
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Purpose: Previous epidemiologic studies have demonstrated an
association of low serum 25-hydroxyvitamin D levels with the
development and progression of osteoarthritis (OA) of the hip and knee.
Potential pathophysiologic mechanisms include effects on chondrocyte
metabolism and immune responses as well as associations with low
bone mineral density. A prior genome-wide association study (GWAS)
demonstrated associations of single nucleotide polymorphisms (SNPs)
in genes involved in vitamin D metabolism with serum 25(OH)D
insufﬁciency (Lancet 2010;376:180–8). The present analysis focused on
whether SNPs in genes within the vitamin D metabolism pathway are
associated with radiographic knee OA.
Methods: We tested for associations between radiographic knee
OA (RKOA) and 271 SNPs falling within 6 Vitamin D metabolism
pathway genes (CYP2R1; CYP24A1, CYP27A1, CYP27B1, GC, VDR) in 3286
participants from the Osteoarthritis Initiative (OAI). Cases (N=2209) had
at least one knee with deﬁnite osteophytes irrespective of the presence
of joint space narrowing (equivalent to Kellgren-Lawrence [KL] grade 2
of higher). Controls (N=1077) had both knees free of both osteophytes
and joint space narrowing (equivalent to KL grade 0). The candidate gene
SNPs were genotyped on the Illumina 2.5M platform as part of the GWAS
of OAI participants. Odds ratios for the association of individual SNPs
and RKOA were estimated from logistic regression analyses adjusted for
age and gender; analyses were conducted separately for Caucasians and
African-Americans. We estimated that the sample size would provide
80% power to detect associations with odds ratios of 1.25–1.37 for SNPs
with minor allele frequencies of 0.10 to 0.50 (a = 0.001).
Results: Demographic features of cases and controls are shown in Table 1.
In single SNP analysis of 2,669 Caucasian subjects, RKOA was nominally
associated with 2 SNPs in CYP2R1 (p < 0.05), 1 SNP in VDR (p < 0.02),
and 1 SNP in CYP24A1 (p < 0.02). Using a gene-wise permutation test
that accounted for correlations among SNPs and the number of SNPs
tested within each gene, none of these associations was smaller than
what would have been expected by chance. In single SNP analysis of
617 African-American subjects, RKOA was nominally associated with
2 SNPs in CYP27A1 (p < 0.03), 1 SNP in VDR (p < 0.03), and 2 SNPs in
CYP24A1 (p < 0.03). After performing the gene-wise permutation test,
there remained weak evidence that the association observed between
CYP24A1 SNP20–52212617 and RKOA (p =0.007) was smaller than would
have been observed by chance after taking into account the multiple
testing within this gene (p =0.06).
Conclusion: These are the ﬁrst preliminary results from the Genome
wide association study of participants in the OAI. They suggest that,
despite weak evidence of an association of a single SNP within
the CYP24A1 gene in African-Americans, genes within the vitamin D
metabolism pathway do not appear to inﬂuence the development of
RKOA in U.S. adults.
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Purpose: To chart the genes and processes involved in the breakdown
of cartilage during osteoarthritis (OA) in a genome wide expression
approach of a considerable number (N=33) of matched OA affected and
preserved cartilage samples using microarrays.
Methods: For 33 patients of the research osteoarthritis and articular
cartilage (RAAK) study (mean age 66.2, range 54–80) we collected
paired cartilage samples at joint replacement surgeries. Affected (near
lesion) areas were matched by preserved (distant from lesion) areas
within each single joint. We included both hip (N=22) and knee
(N=11) replacements. By use of microscopic assessment a scoring of
the cartilage damage was made according to Mankin which takes both
cellular and matrix features of OA into account. RNA was isolated by use
of cryogenic disintegration of the cartilage followed by Qiagen column
extraction and checked for quality (RIN > 8.0) and quantity by lab-on-
a-chip techniques before applying the standard protocol for Illumina
microarray measurements on the HT12-v3-microarrays. After micro-
array analyses all 33 sample pairs passed basic quality control. Analysis
of the data was performed using ’R’ and the Limma package identifying
the most signiﬁcantly up- or downregulated single genes, corrected for
multiple testing (Holm’s method).
Results: Although for some samples the preserved areas did show
signs of OA damage, the Mankin grading for cartilage indicated overall
less damage within the preserved areas as compared to the matched
affected cartilage areas. In total, we detected 206 probes (representing
183 genes) which were differentially expressed with a Holm adjusted
P-value <0.05, irrespective of fold changes of expression. Amongst
these were genes associated to inﬂammation, the complement system,
development, matrix associated genes and several genes involved in
neuronal processes.
When we prioritized the data for genes that showed a fold change of
at least 2, we found the expression to be decreased for 5 genes and
increased for 15 genes in affected as compared to matched preserved
cartilage (23 corresponding probes). The markedly up-regulated genes
belong to pathways which are the usual suspects for involvement in
OA being; inﬂammation (prostaglandin E synthase (PTGES), chemokine
ligand 14 (CXCL14)) and developmental or matrix associated genes
(osteopontin (SPP1), frizzled related protein (FRZB), collagen type IX alpha
1 (COL9A1)). More remarkable, we observed extensive and signiﬁcant up-
regulation of the nerve growth factor (NGF) gene.
Conclusions: This is the ﬁrst analysis of micro-array expression data of
a large number of OA affected cartilage samples matched by preserved
cartilage from the same joint. We show differential expression 183 genes
reﬂecting several processes that may mark the ongoing OA process in
human cartilage. Possibly, amongst these genes are potent therapeutic
targets which may be targeted to stop the process of cartilage breakdown.
